UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug

Dec 24 (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc.

from Reuters: Hot Stocks http://ift.tt/16Qg9Qn